お知らせ • Feb 12
CID HoldCo, Inc. Receives Deficiency Notices from the Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market LLC
On February 5, 2026, CID HoldCo, Inc. received deficiency notices from the Nasdaq Listing Qualifications staff (the Staff") of The Nasdaq Stock Market LLC (Nasdaq") notifying the Company that for the last 30 consecutive business days the Company's securities (i) have not maintained the minimum bid price of at least $1 per share required by the continued listing requirements of Nasdaq Listing Rule 5450(a)(1) (the Minimum Bid Price Notice"), and (ii) have not maintained the minimum Market Value of Listed Securities (MVLS) of $50,000,000 required by the continued listing requirements of Nasdaq Listing Rule 5450(b)(2)(A) (the MVLS Notice"). The MVLS Notice also noted that the Company does not meet the minimum total assets and total revenue requirements of at least $50 million each for the most recently completed fiscal year or two of the three most recently completed fiscal years required by the continued listing requirements of Nasdaq Listing Rule 5450(b)(3)(A). On February 10, 2026, the Company received another deficiency notice from Nasdaq notifying the Company that for the last 30 consecutive business days the Company's securities have not maintained a minimum market value of their publicly held shares of $15.0 million pursuant to Nasdaq Listing Rule 5450(b)(2)(C) (the MVPHS Notice" and together with the Minimum Bid Price Notice and the MVLS Notice, the Notices"). The Notices have no immediate effect on the listing of the Company's common stock on the Nasdaq Global Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A) and 5810(c)(3)(C), the Company has 180 calendar days, or until August 4, 2026 (the Minimum Bid Price and MVLS Compliance Date"), to regain compliance with each of (i) the minimum bid price requirement by having the Company's bid price close at $1 per share or more for a minimum of 10 consecutive business days before the Compliance Date, and (ii) the minimum market value of listed securities (MVLS") of $50,000,000, subject in each case, to the Staff's discretion to extend this period under Nasdaq Listing Rule 5810(c)(3)(H). Additionally, in accordance with Nasdaq Listing Rule 5810(c)(3)(D) the Company has 180 calendar days, or until August 10, 2026 (the MVPHS Compliance Date" and together with the Minimum Bid Price and MVLS Compliance Date, each a Compliance Date"), to regain compliance with the MVPHS requirement. If the Company does not regain compliance with minimum bid price requirements by the Minimum Bid Price and MVLS Compliance Date, the Company may be eligible for an additional 180-day period to regain compliance, provided that on the Compliance Date the Company has submitted an application to transfer to the Nasdaq Capital Market (along with the payment of all applicable fees) and regained compliance with the applicable MVLS and MVPHS requirements for continued listing and all other applicable standards for initial listing on the Nasdaq Capital Market (except the bid price requirement) based on the Company's most recent public filings and market information and notifies Nasdaq of its intent to cure this deficiency. However, if it appears to the Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible for the second compliance period, and the Company does not regain compliance by the Compliance Date, the Staff will provide written notification that the Company's common stock is subject to delisting. Additionally, if the Company does not regain compliance with MVLS and MVPHS requirements by the applicable Compliance Date, the Staff will provide written notification that the Company's common stock is subject to delisting and the Company may consider submitting an application to transfer to the Nasdaq Capital Market (along with the payment of all applicable fees). At such time, the Company may appeal any delisting determination to a hearings panel pursuant to the procedures set in the applicable Nasdaq listing rules. However, there can be no assurance that, if the Company receives a delisting notice and appeals the delisting determination by Nasdaq to the panel, such appeal would be successful. The Company intends to actively monitor the bid price of its common stock between now and the applicable Compliance Date and, as appropriate, plans to evaluate available options to resolve the deficiencies and regain compliance with the minimum bid price requirement, MVLS requirement and MVPHS requirement. Each deficiency discussed in the Notices is a separate and unrelated deficiency, and either deficiency, if not cured by the Compliance Date, could be a basis for the delisting of the Company's common stock.